The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Sterile Compounding Pharmacies Market During 2026–2030?
The sterile compounding pharmacies market size has demonstrated significant growth in recent years. Looking ahead, it is projected to increase from $5.62 billion in 2025 to $5.98 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.5%. Factors contributing to its historical growth include the expansion of injectable therapies, heightened hospital pharmacy demand, stricter regulatory enforcement, advancements in oncology drug compounding, and the rising need for specialty medications.
The sterile compounding pharmacies market is set for significant expansion in the coming years. It is forecast to achieve a size of $7.78 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.8%. This projected growth is driven by factors such as biologic drug growth, personalized injectable therapies, hospital capacity constraints, automation adoption, and regulatory standard evolution. Notable trends for the forecast period include outsourcing of sterile compounding, advanced cleanroom technologies, automation in compounding processes, batch-level traceability, and compliance-driven investments.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12073&type=smp
Which Major Drivers Are Influencing The Expansion Of The Sterile Compounding Pharmacies Market?
The sterile compounding pharmacies market is anticipated to expand due to the rising need for personalized medicine. This type of medicine involves utilizing an individual’s genetic or protein data to prevent, diagnose, or treat illnesses. Sterile compounding pharmacies are crucial for delivering personalized medications within a sterile setting, tailoring treatments to specific patient requirements and mitigating potential adverse reactions to particular dosages or drug components. This approach enhances therapeutic outcomes, boosts patient contentment, and improves adherence to treatment plans. As an illustration, the Personalized Medicine Coalition, a US-based non-profit organization, reported in February 2024 that the FDA cleared 16 new personalized therapies for rare disease patients in 2023, marking a notable rise from the six approvals in 2022. Consequently, the growing desire for personalized medicine is fueling the sterile compounding pharmacies market.
How Is Segmentation Applied In The Sterile Compounding Pharmacies Market Segment Analysis?
The sterile compounding pharmacies market covered in this report is segmented –
1) By Product: Injectables, Nasal, Ocular, Otic
2) By Therapeutic Area: Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Other Therapeutic Areas
3) By Route Of Administrations: Intravenous, Intramuscular, Subcutaneous
4) By End-Users: Adults, Pediatrics, Geriatrics, Veterinary
Subsegments:
1) By Injectables: Sterile Solutions, Sterile Suspensions, Sterile Powders For Reconstitution
2) By Nasal: Nasal Sprays, Nasal Solutions, Nasal Gels
3) By Ocular: Ophthalmic Solutions, Ophthalmic Suspensions, Ocular Inserts
4) By Otic: Otic Solutions, Otic Suspensions, Otic Gels
Which Trends Are Shaping The Sterile Compounding Pharmacies Market?
Leading firms within the sterile compounding pharmacies market are prioritizing technological innovations, specifically robotic automation, to improve the safety, effectiveness, and expandability of sterile compounding operations. These robotic systems incorporate sophisticated monitoring, verification, and labeling technologies to guarantee adherence to rigorous regulatory guidelines and preserve the quality of products. An example occurred in March 2023 when Omnicell Inc., a US healthcare technology company, launched its IVX Station, a robotic compounding solution designed to automate sterile compounding within an ISO Class 5 setting. This system is equipped with ongoing temperature, humidity, and particle surveillance, sophisticated vision capabilities, gravimetric validation, automatic labeling, and machine-driven application of tamper-evident syringe caps. Furthermore, its cloud-based formulation library undergoes continuous updates, providing scalable availability of the most current authorized formulations and facilitating high-volume, secure, and efficient pharmacy functions.
Who Are The Companies Participating In The Sterile Compounding Pharmacies Market Environment?
Major companies operating in the sterile compounding pharmacies market are B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter’s House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., Absolute Pharmacy Inc.
Get The Full Sterile Compounding Pharmacies Market Report:
Which Region Represents The Largest Share Of The Sterile Compounding Pharmacies Market?
North America was the dominant region in the sterile compounding pharmacies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile compounding pharmacies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Sterile Compounding Pharmacies Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Sterile Compounding Pharmacies Market 2026, By The Business Research Company
Sterile Medical Packaging Market Report 2026
https://www.thebusinessresearchcompany.com/report/sterile-medical-packaging-global-market-report
Pharmacies And Drug Stores Market Report
https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report
Depyrogenated Sterile Empty Vials Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model